The effect of lifestyle and risk factor modification on occlusive peripheral arterial disease outcomes: standard healthcare vs structured programme—for a randomised controlled trial protocol

BACKGROUND: Peripheral arterial disease (PAD) affects more than 200 million of the global population. PAD represents a marker for premature cardiovascular events. Patients with PAD, even in the absence of a history of myocardial infarction or ischemic stroke, have approximately the same relative ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfghi, M., Jordan, F., Dunne, D., Gibson, I., Jones, J., Flaherty, G., Sultan, S., Tawfick, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881542/
https://www.ncbi.nlm.nih.gov/pubmed/33581715
http://dx.doi.org/10.1186/s13063-021-05087-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881542/
https://www.ncbi.nlm.nih.gov/pubmed/33581715
http://dx.doi.org/10.1186/s13063-021-05087-x

Ejemplares similares